{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:24:35Z","timestamp":1793118275432,"version":"4.5.0"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007923","name":"Yangtze University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.gene.2026.150256","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T23:59:15Z","timestamp":1780531155000},"page":"150256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["A systematic evaluation of the efficacy and safety of entrectinib in anaplastic thyroid carcinoma"],"prefix":"10.1016","volume":"1006","author":[{"given":"Ran","family":"Jie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiawei","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gene.2026.150256_b0005","doi-asserted-by":"crossref","first-page":"E174","DOI":"10.1002\/dc.24945","article-title":"Cytological and molecular characterization of secretory breast carcinoma","volume":"50","author":"Carretero-Barrio","year":"2022","journal-title":"Diagn. Cytopathol."},{"key":"10.1016\/j.gene.2026.150256_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.lungcan.2023.107442","article-title":"Updated efficacy and safety of entrectinib in NTRK fusion-positive non-small cell lung cancer","volume":"188","author":"Cho","year":"2024","journal-title":"Lung Cancer"},{"key":"10.1016\/j.gene.2026.150256_b0015","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1158\/0008-5472.CAN-09-1947","article-title":"Drug combination studies and their synergy quantification using the Chou-Talalay method","volume":"70","author":"Chou","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.gene.2026.150256_b0020","article-title":"Retroelements in thyroid cancer: epigenetic plasticity, dedifferentiation, and therapeutic opportunities","author":"D'Alessandre","year":"2025","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.gene.2026.150256_b0025","doi-asserted-by":"crossref","DOI":"10.1530\/ETJ-22-0179","article-title":"Entrectinib in the neoadjuvant setting of anaplastic thyroid cancer: a case report","volume":"12","author":"Damasio","year":"2023","journal-title":"Eur. Thyroid J."},{"key":"10.1016\/j.gene.2026.150256_b0030","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1158\/1078-0432.CCR-21-3597","article-title":"Updated integrated analysis of the efficacy and safety of entrectinib in patients with NTRK fusion-positive solid tumors","volume":"28","author":"Demetri","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.gene.2026.150256_b0035","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1093\/neuonc\/noac087","article-title":"Entrectinib in children and young adults with solid or primary CNS tumors harboring NTRK, ROS1, or ALK aberrations (STARTRK-NG)","volume":"24","author":"Desai","year":"2022","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.gene.2026.150256_b0040","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2174\/1568009623666230904150957","article-title":"Regulating tumorigenicity and cancer metastasis through TRKA signaling","volume":"24","author":"Fan","year":"2024","journal-title":"Curr. Cancer Drug Targets"},{"key":"10.1016\/j.gene.2026.150256_b0045","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23042124","article-title":"NGF\/TRKA promotes ADAM17-dependent cleavage of P75 in ovarian cells: elucidating a pro-tumoral Mechanism","volume":"23","author":"Garrido","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.gene.2026.150256_b0050","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.pathol.2020.08.009","article-title":"The neurotrophic tyrosine kinase receptor 1 (TrkA) is overexpressed in oesophageal squamous cell carcinoma","volume":"53","author":"Griffin","year":"2021","journal-title":"Pathology"},{"key":"10.1016\/j.gene.2026.150256_b0055","article-title":"Entrectinib, a new multi-target inhibitor for cancer therapy","volume":"150","author":"Jiang","year":"2022","journal-title":"Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie"},{"key":"10.1016\/j.gene.2026.150256_b0060","doi-asserted-by":"crossref","DOI":"10.1530\/ETJ-25-0057","article-title":"Novel insights in advanced thyroid carcinoma: from mechanisms to treatments: Molecular insights into the origin, biology, and treatment of anaplastic thyroid carcinoma","volume":"14","author":"Karimi","year":"2025","journal-title":"Eur. Thyroid J."},{"key":"10.1016\/j.gene.2026.150256_b0065","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1017\/S0022215124001087","article-title":"Treatment and management of anaplastic thyroid carcinoma: appraisal of clinical practice guidelines","volume":"139","author":"Kuriakose","year":"2025","journal-title":"J. Laryngol. Otol."},{"key":"10.1016\/j.gene.2026.150256_b0070","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s10549-019-05506-3","article-title":"TrkA overexpression in non-tumorigenic human breast cell lines confers oncogenic and metastatic properties","volume":"179","author":"Kyker-Snowman","year":"2020","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.gene.2026.150256_b0075","article-title":"Prognostic value of neurotrophic tyrosine receptor kinase gene fusions in solid tumors for overall survival: a systematic review and meta-analysis","volume":"7","author":"Lassen","year":"2023","journal-title":"JCO Precis. Oncol."},{"key":"10.1016\/j.gene.2026.150256_b0080","first-page":"87","article-title":"Characterization of thyroid cancer cell lines in murine orthotopic and intracardiac metastasis models, Horm","volume":"6","author":"Morrison","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.gene.2026.150256_b0085","first-page":"195","article-title":"Trk receptor tyrosine kinases in metastasis and cancer therapy","volume":"28","author":"Regua","year":"2019","journal-title":"Discov. Med."},{"key":"10.1016\/j.gene.2026.150256_b0090","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s12022-025-09876-x","article-title":"Diagnostic evaluation of anaplastic thyroid carcinoma in core biopsy specimens: morphologic, immunohistochemical, molecular, and therapeutic considerations","volume":"36","author":"Riascos","year":"2025","journal-title":"Endocrine Pathology"},{"key":"10.1016\/j.gene.2026.150256_b0095","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.amjms.2017.03.025","article-title":"Antiviral drug ribavirin targets thyroid cancer cells by inhibiting the eIF4E-beta-catenin axis","volume":"354","author":"Shen","year":"2017","journal-title":"Am. J. Med. Sci."},{"key":"10.1016\/j.gene.2026.150256_b0100","article-title":"Anaplastic thyroid carcinoma: a contemporary review of challenges and advances","author":"Silver Karcioglu","year":"2025","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.gene.2026.150256_b0105","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23010395","article-title":"Entrectinib induces apoptosis and inhibits the epithelial-mesenchymal transition in gastric cancer with NTRK overexpression","volume":"23","author":"Sohn","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.gene.2026.150256_b0110","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1186\/s12885-024-13271-w","article-title":"NTRK fusion promotes tumor migration and invasion through epithelial-mesenchymal transition and closely interacts with ECM1 and NOVA1","volume":"24","author":"Zeng","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.gene.2026.150256_b0115","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1186\/s12935-025-03971-z","article-title":"Post-translational modifications in anaplastic thyroid carcinoma: biological mechanisms and therapeutic potential","volume":"25","author":"Zhong","year":"2025","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.gene.2026.150256_b0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.gendis.2024.101403","article-title":"Anaplastic thyroid cancer: Genetic roles, targeted therapy, and immunotherapy","volume":"12","author":"Zou","year":"2025","journal-title":"Genes & Diseases"}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111926002660?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111926002660?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T16:22:31Z","timestamp":1782404551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111926002660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":24,"alternative-id":["S0378111926002660"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2026.150256","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic evaluation of the efficacy and safety of entrectinib in anaplastic thyroid carcinoma","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2026.150256","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"150256"}}